August 06, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
FDA approves first mRNA flu shot, mFlusiva
The FDA has approved the nation’s first messenger RNA-based influenza vaccine, marking a significant development in the fight against the respiratory illness — and the end of a tumultuous approval process. The vaccine (mFlusiva, Moderna) is approved for adults aged 50 years or older. It is the fifth mRNA vaccine approved for use in the United States, which include Moderna’s two COVID-19 shots and
845 words~4 min read
